This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University of California. Active years: 2008-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2017
Title: Hye-Won Shin: Innovator in Asthma Treatment and Bioreactor Technology
Introduction
Hye-Won Shin is a prominent inventor based in Irvine, California. She has made significant contributions to the fields of asthma treatment and bioreactor technology. With a total of 3 patents, her work focuses on improving medication compliance and understanding volatile organic compounds in biological cultures.
Latest Patents
One of Hye-Won Shin's latest patents is titled "Approach to asthma inhaler compliance using breath measurement of tetrafluoroethane." This invention relates to measuring the effectiveness and compliance of inhaler medication, particularly for asthma treatment. In one embodiment, the invention provides a method of determining the effectiveness of an inhaler medication by measuring HFA-134(a) from an exhaled breath after the individual has inhaled the medication. The effectiveness of the medication is determined based on the presence of a high level of HFA-134(a).
Another notable patent is the "Bioreactor for quantification of headspace VOC content from cultures." This bioreactor is designed for sampling the headspace above cells and includes a glass reactor vessel with a plurality of valves. The interior space of the bioreactor contains a charge of air with a known composition of volatile organic gases, which may include specific VOC constituents such as acetaldehyde and hexanaldehyde.
Career Highlights
Hye-Won Shin is affiliated with the University of California, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on healthcare and environmental monitoring.
Collaborations
Hye-Won has collaborated with notable colleagues, including Dan M Cooper and Donald R Blake, contributing to a rich environment of innovation and research.
Conclusion
Hye-Won Shin's contributions to asthma treatment and bioreactor technology highlight her role as a leading inventor in her field. Her innovative patents reflect her commitment to improving health outcomes and advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile